Cannabis Research

He was against it until he was for it. Republican John Boehner, the former Speaker of the House, once said he was “unalterably opposed” to marijuana legalization. But the meaning of “unalterable” seems to have altered. This month, he joined the advisory board of Acreage Holdings, among the largest cannabis companies in the United States […]

by

Dr. Orser’s research focuses on the methodical classification of cultivars of the Cannabis sativa plant through broad genotypic and chemotypic analysis that includes not only cannabinoids but also terpenoids. Dr. Orser’s research has found that unique terpenoid chemoprofile patterns exist and can be assigned to specific cultivars. Eventually, this data analysis is expected to end […]

by

BOSTON — As Massachusetts prepares to roll out retail marijuana sales, the state is devoting little if any money to researching the impact of legal pot use. While marijuana remains illegal under federal law, which tightly restricts scientific research of the drug, the state’s new pot law actually requires that regulators study the effects of […]

by

The nation’s leading sleep medicine group is opposing the use of medical cannabis and synthetic marijuana extracts for the treatment of obstructive sleep apnea (OSA). Late last year, the Minnesota Department of Health announced that OSA would be added to the state’s medical cannabis program list of chronic medical conditions. But in a newly published […]

by

Scientific research is proving more and more medical uses for cannabis. Experts cite medical marijuana as an effective treatment to use in conjunction with other medications, often to decrease their side effects. For example, people with epilepsy, cancer and HIV frequently use cannabis. Furthermore, many people choose to smoke weed instead of drink alcohol when they’re […]

by

An employee checks cannabis plants at a medical marijuana plantation in northern Israel March 21, 2017. REUTERS/Nir Elias The legal cannabis sector is expected to surge from $7.7 billion to $31.4 billion between 2017 and 2021. It’s estimated that North American sales will make up 86% of the global market. There are a variety of […]

by

When Sylvie Lammert had her first seizure at nine months old, she was rushed to an emergency room where doctors couldn’t find an apparent cause. It would be the first of five seizures she had that day. X During the last seizure, it took medical personnel 30 minutes before they could bring the baby’s tiny, convulsing […]

by

Right now, there are few industries growing more quickly and consistently than legal cannabis. Estimates from cannabis research firm ArcView, in partnership with BDS Analytics, call for North American sales growth to average 28% each year through 2021, leading to almost $25 billion in sales. A decade from now we could be looking at around […]

by

The swift regulatory changes taking place in the global cannabis sector are almost without modern precedent. While some find the situation analogous to the repeal of Prohibition in the United States, it’s also fair to point out that such events happened 85 years ago in the midst of the Great Depression. It was a long […]

by

Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors. Global Cannabis Research Leaders Beckley Foundation and Canopy Health Innovations Partner to Form Beckley Canopy Therapeutics SMITHS FALLS, ON and OXFORD, UK, April 9, 2018 /CNW/ – Canopy Growth Corporation (TSX: WEED) […]

by

John A. Boehner, the former Republican speaker of the House who once said he was “unalterably opposed” to decriminalizing marijuana laws, has joined a board of directors for a cannabis company with an eye on rolling back federal regulations. The former Ohio congressman has been appointed to the board of advisers of Acreage Holdings, invoking the need for veterans to access the drug legally to explain his change […]

by